9/28/2017 - Launch of ProFeno Tablets (NSAID)
WraSer Pharmaceuticals, a privately held pharmaceutical company located in Ridgeland, Mississippi has launched ProFeno Tablets for the management of pain and inflammation related to OA and RA in adults. For more information, please visit www.profenorx.com ... read more

9/28/2017 - Launch of ZoDex Tapered Steroid Pack
WraSer Pharmaceuticals, a privately held pharmaceutical company located in Ridgeland, Mississippi has launched ZoDex 6-Day and 12-Day tapered steroid packs. ZoDex is a BP rated product and not equivalent to any other Dexamethasone containing product on the market. ZoDex is indicated for a variety of inflammatory ailments ... read more

1/1/2015 - Launch of Prescription Trezix
Wraser Receives FDA Approval on Trezix Capsules, CIII for Moderate to Moderately Severe Pain December 4th, 2014 Ridgeland, M.S.(BUSINESS WIRE)Wraser Pharmaceuticals, LLC, a specialty pharmaceutical company, today announced that it has received FDA Approval on Trezix (acetaminophen / caffeine / dihydrocodeine bitartrat ... read more

10/5/2012 - License and Launch of REGIMEX
WraSer Pharmaceuticals, LLC to launch REGIMEX capsules. RIDGELAND, MS October 5th, 2012 WraSer Pharmaceuticals, LLC (WraSer) a privately held Ridgeland, Mississippi based pharmaceutical company, is pleased to announce the license and launch of the brand, REGIMEX. WraSer Pharmaceuticals will target key weight loss medical pr ... read more

3/13/2012 - Strategic Promotion of ENTEX Formulations
WraSer Pharmaceuticals, LLC to launch key ENTEX formulations. RIDGELAND, MS March 13, 2012 WraSer Pharmaceuticals, LLC (WraSer) a privately held Ridgeland, Mississippi based pharmaceutical company, is pleased to announce the development and launch of the successful brand, ENTEX to reinforce its commitment to otolary ... read more

11/7/2011 - Cetraxal professional sample recall notice
For Immediate Release - Professional Samples Recall     WraSer Pharmaceuticals Announces the Recall of Cetraxal® (ciprofloxacin otic solution) 0.2% professional samples, Lot #s F09019, G09051, G09052, G09083   Ridgeland, MS – November 7, 2011 – Mississippi based WraSer Pharmaceuticals ann ... read more

7/15/2011 - Partnership between WC Pharmaceticals and WraSer Pharmaceuticals
For Immediate Release   Women’s Choice Pharmaceuticals Announces the Co-Promotion Agreement for Trezix® Oral Capsules(Acetaminophen 356.4mg/Caffeine 30 mg/Dihydrocodeine 16 mg)   Gilbert, AZ – July 15, 2011 – Gilbert-based Women’s Choice Pharmaceuticals (WC Pharma) announced today i ... read more

5/16/2011 - Partnership between WraSer and Pedinol Pharmacal, Inc.
May 1, 2011   For Immediate Release   WraSer Pharmaceuticals, LLC announces an exclusive co-detail of Nalfon® capsules (fenoprofen calcium, USP) 200mg and 400mg from Pedinol Pharmacal, Inc.   Ridgeland, MS (May 1, 2011) – WraSer Pharmaceuticals, LLC (WraSer) announced today it has entered into ... read more

6/1/2010 - WraSer Pharmaceuticals, LLC Launches Instant Rebate Programs
June 1, 2010   For Immediate Release   WraSer Pharmaceuticals, LLC Announces the launch of two new Instant Rebate programs to assist in patients’ out-of-pocket costs of prescription Cetraxal® and Xolox™.   Ridgeland, MS (June 1, 2010) – WraSer Pharmaceuticals, LLC (WraSer) announce ... read more

7/22/2009 - WraSer Pharmaceuticals, LLC Announces the Purchase of FDA Approved Trezix
July 22, 2009   For Immediate Release   WraSer Pharmaceuticals,LLC Announces the Purchase of Trezix® Oral Capsules (Acetaminophen 356.4mg/Caffeine 30 mg/Dihydrocodeine 16 mg) from e5 Pharma, LLC.   Ridgeland, MS (July 22, 2009) – WraSer Pharmaceuticals, LLC (WraSer) announced today that it has ... read more

7/9/2009 - Laboratorios SALVAT, S.A. and WraSer Pharmaceuticals, LLC Announce Exclusive License Agreement for the Commercialization of CETRAXAL (ciprofloxacin otic solution) 0.2%
July 9, 2009   For Immediate Release   Laboratorios SALVAT, S.A. and WraSer Pharmaceuticals, LLC Announce Exclusive License Agreement for the Commercialization of CETRAXAL® (ciprofloxacin otic solution) 0.2%.   BARCELONA, SPAIN and RIDGELAND, MS (June 29, 2009) — Laboratorios SALVAT, S.A. (SA ... read more

12/8/2008 - WraSer Pharmaceuticals, LLC agrees to promote three key branded topical dermatology products for Ranbaxy Laboratories, Inc.
WraSer Pharmaceuticals, LLC agrees to promote three key branded topical dermatology products for Ranbaxy Laboratories, Inc.   MADISON, MS – October 24, 2008 – WraSer Pharmaceuticals, LLC (WraSer) a privately held Madison, Mississippi based pharmaceutical company, is pleased to announce it has entered int ... read more

5/1/2008 - Partnership between WraSer & Ole Miss
UM Researcher Featured at IP Forum The University of Mississippi was among the five leading research institutions represented at the inaugural MRC/MTA Intellectual Property Forum and Technology Expo, held November 30-December 1 in Jackson. Among the spotlighted presenters was Dr. Michael Repka, assistant professor in the D ... read more

4/24/2008 - New Website
WraSer Pharmaceuticals is pleased to announce and launch our new website.  There are several new features that have been incorporated to help physicians, pharmacists, and patients navigate our site regarding products, contact information, and customer service. ... read more